Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Julia Rawlings

Concepts (55)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Safety Management
2
2018
130
0.600
Why?
Patient Safety
2
2018
351
0.500
Why?
Pharmacy Service, Hospital
1
2018
90
0.480
Why?
Organizational Culture
1
2018
159
0.480
Why?
Remote Consultation
1
2022
67
0.170
Why?
Drug Overdose
1
2022
376
0.130
Why?
Pharmacy
1
2017
32
0.120
Why?
Pharmaceutical Services
1
2017
76
0.120
Why?
Benchmarking
1
2017
192
0.110
Why?
Opioid-Related Disorders
1
2022
611
0.100
Why?
Pharmacists
1
2017
260
0.100
Why?
Colchicine
1
2012
20
0.090
Why?
Gout Suppressants
1
2012
18
0.090
Why?
Gout
1
2012
34
0.090
Why?
Hematologic Diseases
1
2012
66
0.090
Why?
Chemical and Drug Induced Liver Injury
1
2012
138
0.080
Why?
Renal Insufficiency
1
2012
172
0.080
Why?
Delivery of Health Care
1
2017
942
0.080
Why?
Attitude of Health Personnel
1
2018
1212
0.070
Why?
Cross-Sectional Studies
2
2018
5875
0.070
Why?
Surveys and Questionnaires
2
2018
6050
0.070
Why?
Endrin
1
2022
13
0.050
Why?
Sumatriptan
1
1999
6
0.040
Why?
Health Maintenance Organizations
1
1999
105
0.030
Why?
Colorado
2
2022
4588
0.030
Why?
Migraine Disorders
1
1999
109
0.030
Why?
Pain
1
2022
787
0.030
Why?
Pharmacies
1
2017
40
0.030
Why?
Analgesics, Opioid
1
2022
1158
0.030
Why?
Counseling
1
2017
403
0.020
Why?
Practice Patterns, Physicians'
1
2022
1370
0.020
Why?
Humans
5
2022
145625
0.020
Why?
Cytochrome P-450 CYP3A Inhibitors
1
2012
18
0.020
Why?
Cytochrome P-450 CYP3A
1
2012
93
0.020
Why?
Insurance, Health, Reimbursement
1
2012
97
0.020
Why?
Drug Interactions
1
2012
403
0.020
Why?
Communication
1
2017
979
0.020
Why?
Enzyme Inhibitors
1
2012
820
0.020
Why?
United States
2
2022
16041
0.020
Why?
Prevalence
1
2012
2852
0.010
Why?
Case-Control Studies
1
2012
3633
0.010
Why?
Electronic Health Records
1
2012
1208
0.010
Why?
Cohort Studies
1
2012
6045
0.010
Why?
Efficiency
1
1999
102
0.010
Why?
Health Services
1
1999
112
0.010
Why?
Statistics, Nonparametric
1
1999
423
0.010
Why?
Cost of Illness
1
1999
322
0.010
Why?
Young Adult
1
2012
14240
0.010
Why?
Middle Aged
2
2012
36359
0.010
Why?
Patient Satisfaction
1
1999
698
0.010
Why?
Adult
2
2012
40821
0.010
Why?
Aged
1
2012
26251
0.010
Why?
Male
2
2012
73014
0.000
Why?
Female
2
2012
79080
0.000
Why?
Quality of Life
1
1999
3187
0.000
Why?
Rawlings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)